Non surgical fat reduction can be achieved with Energy Based Devices (EBD) such as cryolipolisys or by dehoxycholate (DC) injections; moving an EBD can be difficult and cumbersome, therefore, these systems may not be practical for physicians who work in multiple locations. Injectable treatments do not have this disadvantage and can therefore be performed on demand1-3. Moreover, EBDs must be purchased upfront, whereas a supply of injectables can be purchased as needed, when needed2. Nowadays ATX-101 is the only approved drug containing DC: the sole purpose of this drug is to reduce unwanted submental fullness. ATX- 101 was introduced into the US and Canadian markets in 2015 and into the European market in 20172
Non surgical fat reduction with dehoxycholate: An update regarding available solutions in the european market / Rauso, R.; Fragola, R.; Nicoletti, G. F.; Chirico, F.; Lo Giudice, G.; Nikolli, E.; Zerbinati, N.. - In: AESTHETIC MEDICINE. - ISSN 2421-7115. - 7:2(2021), pp. 55-58.
Non surgical fat reduction with dehoxycholate: An update regarding available solutions in the european market
Rauso R.;Chirico F.;
2021
Abstract
Non surgical fat reduction can be achieved with Energy Based Devices (EBD) such as cryolipolisys or by dehoxycholate (DC) injections; moving an EBD can be difficult and cumbersome, therefore, these systems may not be practical for physicians who work in multiple locations. Injectable treatments do not have this disadvantage and can therefore be performed on demand1-3. Moreover, EBDs must be purchased upfront, whereas a supply of injectables can be purchased as needed, when needed2. Nowadays ATX-101 is the only approved drug containing DC: the sole purpose of this drug is to reduce unwanted submental fullness. ATX- 101 was introduced into the US and Canadian markets in 2015 and into the European market in 20172I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
